Compound Q&A
What is the market or research trend for Avatrombopag (CAS: 570406-98-3)?
Answer
The market for Avatrombopag (CAS: 570406-98-3) is driven by growing demand in the treatment of thrombocytopenia. Research trends focus on its efficacy and safety in various clinical settings, including its use in hematological disorders and post-surgical conditions. Market trends indicate increasing interest in this TPO agonist as a therapeutic option.
About
CAS No
570406-98-3
English Name
Avatrombopag
Molecular Formula
C29H34Cl2N6O3S2
Molecular Weight
649.67 g/mol
SMILES
C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl
InChIKey
OFZJKCQENFPZBH-UHFFFAOYSA-N
Last Updated: 2025-10-21 00:33
